We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




PICC Use May Cause Blood Clots in All Extremities

By HospiMedica International staff writers
Posted on 23 Aug 2015
A new study indicates that peripherally inserted central catheters (PICCs) could potentially lead to deep vein thrombosis (DVT) in the lower extremities, as well as the upper ones. More...


Researchers at the at the University of Michigan (Ann Arbor, USA) and other institutions participating in the Michigan Hospital Medicine Safety Consortium (Ann Arbor, MI, USA) conducted a multicenter, retrospective cohort study of 76,242 hospitalized medical patients from 48 Michigan hospitals to examine the risk of DVT in deep veins of the arm, leg, and chest after PICC placement. The main outcomes were thrombotic events within 90 days from hospital admission, as ascertained by phone and record review.

In all, 3,790 patients received a PICC during hospitalization. Analysis revealed 876 thromboembolic events, including 208 upper-extremity DVTs, 372 lower-extremity DVTs, and 296 pulmonary emboli (PE). After adjustment, PICC use was independently associated with a three-fold higher risk for any type of thromboembolic event, compared to patients who had not received a PICC. DVT risk was more than 10 times higher in the upper extremity and nearly 50% higher in the lower-extremity DVT. There was no increased risk of pulmonary embolism from PICC use. The study was published on May 1, 2015, in the American Journal of Medicine.

“Careful weighing of the risks and benefits of PICC use and consideration of alternative devices in patients at high risk of deep vein thrombosis seem essential,” concluded senior author Vineet Chopra, MD, MSc, and colleagues. “Clinicians should not focus only on the extremity where a peripherally inserted central catheter resides, but the composite risk of venous thromboembolism among patients who receive a peripherally inserted central catheter.”

PICCs have become the preferred device through which to administer long-term intravenous (IV) fluids, antibiotics, and other drugs because they have lower risks of infection, can be conveniently placed at the bedside, and can stay in place for long periods of time. The ability to keep PICCs in for weeks or even months also allows patients who need a constant flow of medications to go home with these catheters.

Related Links:

University of Michigan
The Michigan Hospital Medicine Safety Consortium



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.